Barclays analyst Emily Field maintained a Hold rating on GlaxoSmithKline (GSK – Research Report) today and set a price target of £15.50.

UBS analyst Jo Walton maintained a Hold rating on GlaxoSmithKline (GSK – Research Report) today and set a price target of p1,580.00. The ...

In 2023, the market is anticipated to be valued at USD 26.64 Billion, marking a significant starting point for a decade-long ...

The Industry is on the brink of a substantial surge, with the market size expected to reach USD 100 Million in 2023 and ...

In patients with moderate to severe Crohn’s disease, guselkumab showed similar efficacy in both biologic-naive and ...

A persistent, often progressive, lung disease, COPD results from chronic inflammation that leads to structural changes ...

Hindustan Unilever (HUL)- the country's leading FMCG player will come up with its Q2 earnings on October 23, 2024 (Wednesday) ...

Earnings before interest, tax, depreciation, and amortisation (Ebitda) is likely to remain flat at Rs 3,698.7 crore on an ...

SBI Securities has recommended buying shares of Coal India, Macrotech Developers, Bharti Hexacom, Nippon Life India, Escorts ...

Nigeria’s manufacturing sector is under siege. The cruel combination of high energy costs, foreign exchange scarcity, rising ...

Genoa Ventures, a venture capital firm investing in science-driven companies of consequence, is proud to announce the ...

Healthcare decision-makers are facing significant challenges that will intensify in the coming years as they work to address ...